40 results on '"Hoogwerf Byron J"'
Search Results
2. Results of a 24-Week Trial of Technosphere Insulin Versus Insulin Aspart in Type 2 Diabetes
3. Hypoglycemia in Older Patients
4. Risk Factors for Nocturnal Hypoglycemia in Insulin-treated Patients With Type 2 Diabetes: A Secondary Analysis of Observational Data Derived From an Integrated Clinical Trial Database
5. Effects of Exenatide on Kidney Function, Adverse Events, and Clinical End Points of Kidney Disease in Type 2 Diabetes
6. Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study
7. Clinical Outcomes of Concomitant Therapy of Exenatide Twice Daily and Basal Insulin In Patients with Type 2 Diabetes Mellitus: A Retrospective Database Analysis In the United States
8. Efficacy of GLP-1 Receptor Agonists and DPP-4 Inhibitors: Meta-Analysis and Systematic Review
9. Use of Concomitant Glucose-Lowering Therapies and Associated Treatment Results Observed in Clinical Trials of Twice-Daily Exenatide
10. Is the tolerability of long-term thiazolidinedione therapy overstated? Reply
11. Renin–Angiotensin System Blockade and Cardiovascular and Renal Protection
12. Emerging Cardiovascular Risk Factors That Account for a Significant Portion of Attributable Mortality Risk in Chronic Kidney Disease
13. Diabetes Mellitus—Overview
14. Abstract #864: Development of Type III Hyperlipoproteinemia With End-Stage Liver Disease and Effects of Liver Transplantation
15. Elevated international normalized ratio in the ED: clinical course and physician adherence to the published recommendations
16. Relation of diurnal blood pressure variation and triglyceride-to-high-density lipoprotein cholesterol ratio in patients without diabetes mellitus
17. Quality of Life After Coronary Artery Bypass Graft
18. Association of dyslipidemia and effects of statins on nonmacrovascular diseases
19. Progression of renal insufficiency in type 2 diabetes with and without microalbuminuria: results of the Heart Outcomes and Prevention Evaluation (HOPE) randomized study
20. Relation of albumin/creatinine ratio to C-reactive protein and to the metabolic syndrome
21. Heart rate and blood pressure responses to mental stress and clinical cardiovascular events in men and women after coronary artery bypass grafting: The Post Coronary Artery Bypass Graft (Post-CABG) biobehavioral study
22. Relation of hemoglobin A1c to left ventricular relaxation in patients with type 1 diabetes mellitus and without overt heart disease
23. Fluid retention after initiation of thiazolidinedione therapy in diabetic patients with established chronic heart failure
24. Angiographic changes in saphenous vein grafts are predictors of clinical outcomes
25. Ectopic Adrenocorticotropic Hormone Syndrome Caused by Metastatic Carcinoma of the Prostate: Therapeutic Response to Ketoconazole
26. Ramipril reduces the risk of developing diabetes in high-risk people
27. Fasting blood glucose in the nondiabetic range is a continuous and graded risk factor for CHD
28. Blood glucose concentrations ≤125 mg/dl and coronary heart disease risk
29. Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk diabetic patients
30. C-reactive protein predicts microalbuminuria
31. Autoantibodies to IA-2 and GAD65 in Patients with Type 2 Diabetes Mellitus of Varied Duration: Prevalence and Correlation with Clinical Features
32. POSTOPERATIVE MANAGEMENT OF THE DIABETIC PATIENT
33. Lessons from the post coronary artery bypass graft study in evaluating and controlling technical variability in angiographic trials∗∗The list of the Post CABG Investigators appears in another publication.
34. Neuroglycopenic and other symptoms in patients with insulinomas
35. Severe Hypertriglyceridemia and Acute Pancreatitis During Pregnancy: Treatment with Gemfibrozil
36. Thyroid-Stimulating Antibody Assay Using a Human Thyrotropin Receptor Transfected Cell Line: Relationship to Clinical Features of Graves’ Disease
37. Surgical endocrinology: Clinical syndromes, 2nd edition
38. Infusion of synthetic human C-peptide does not affect plasma glucose, serum insulin, or plasma glucagon in healthy subjects
39. Effect of clofibrate and colestipol singly and in combination on plasma lipids and lipoproteins in type III hyperlipoproteinemia
40. Long-term weight regulation in treated hyperthyroid and hypothyroid subjects
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.